Drug Trial Radar · NCT07646587
A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
Last checked: Nov 19, 2026Latest source record: Oct 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
105
Planned (sponsor's estimate)
Start
Jun 2, 2026
Primary completion
Dec 17, 2027
Study completion Jan 7, 2028
Sponsor
- Lead sponsor
- Windward BioIndustry
- Sponsor type
- Industry
- First posted
- Jun 12, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 40 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is trying to identify the right dose of a long-acting medicine called WIN378 for people with moderate - severe chronic obstructive pulmonary disease (COPD). WIN378 blocks the action of a protein called TSLP that causes inflammation in the lung and may contribute to COPD control and symptoms. The study will test how doses of WIN378 are handled by the body (pharmacokinetics) and assess the safety of the medicine and markers of COPD inflammation in exhaled breath and blood, lung function and COPD control (pharmacodynamics)
Conditions
- COPD (Chronic Obstructive Pulmonary Disease)
Interventions
WIN378Drug
WIN378 is a fully human, long-acting monoclonal antibody that targets the ligand of thymic stromal lymphopoietin (TSLP), blocking its activity and thereby reducing airway inflammation and improving COPD control over an extended dosing interval
PlaceboDrug
Placebo matching WIN378
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of participants with Adverse Events (AEs)Time frame: Week 0 - Week 36
- Number of participants with Serious Adverse Events (SAEs)Time frame: Week 0 - Week 36
- Change from baseline in systolic blood pressure (mmHg)Time frame: Week 0 - Week 36
- Change from baseline in diastolic blood pressure (mmHg)Time frame: Week 0 - Week 36
- Change from baseline in pulse rate (beats/minute)Time frame: Week 0 - Week 36
- Change from baseline in respiratory rate (breaths/minute)Time frame: Week 0 - Week 36
- Change from baseline in oxygen saturation (%)Time frame: Week 0 - Week 36
- Change from baseline in body weight (kg)Time frame: Week 0 - Week 36
- Change from baseline in body mass index (kg/m^2)Time frame: Week 0 - Week 36
- Change from baseline in body temperature (°C)Time frame: Week 0- Week 36
- Change from baseline in clinical chemistry laboratory assessmentsTime frame: Week 0 - Week 36
- Change from baseline in haematology laboratory parametersTime frame: Week 0 - Week 36
- Change from baseline in coagulation laboratory parametersTime frame: Week 0 - Week 36
- Change from baseline in urinalysis parametersTime frame: Week 0 - Week 36
- Change from baseline in electrocardiogram QT intervalTime frame: Week 0 - Week 36
- WIN378 Serum concentration (PK)Time frame: Week 0 to week 36
Locations
32 sites in 2 countries. Site status is shown where the registry gives one.
WB Contracted Clinical Research Site
Los Angeles, California · Recruiting
WB Contracted Clinical Research Site
Jacksonville, Florida · Recruiting
WB Contracted Clinical Research Site
Miami Lakes, Florida · Recruiting
WB Contracted Clinical Research Site
North Dartmouth, Massachusetts · Recruiting
WB Contracted Clinical Research Site
Charlotte, North Carolina · Recruiting
WB Contracted Clinical Research Site
Medford, Oregon · Recruiting
WB Contracted Clinical Research Site
DuBois, Pennsylvania · Recruiting
WB Contracted Clinical Research Site
McKinney, Texas · Recruiting
WB Contracted Clinical Research Site
Waxahachie, Texas · Recruiting
WB Contracted Clinical Research Site
Bahía Blanca, Buenos Aires, Argentina · Recruiting
WB Contracted Clinical Research Site
Buenos Aires, Buenos Aires, Argentina · Recruiting
WB Contracted Clinical Research Site
Buenos Aires, Buenos Aires, Argentina · Recruiting
WB Contracted Clinical Research Site
Buenos Aires, Buenos Aires, Argentina · Recruiting
WB Contracted Clinical Research Site
Buenos Aires, Buenos Aires, Argentina · Recruiting
WB Contracted Clinical Research Site
Buenos Aires, Buenos Aires, Argentina · Recruiting
WB Contracted Clinical Research Site
Buenos Aires, Buenos Aires, Argentina · Recruiting
WB Contracted Clinical Research Site
Buenos Aires, Buenos Aires, Argentina · Recruiting
WB Contracted Clinical Research Site
Buenos Aires, Buenos Aires, Argentina · Recruiting
WB Contracted Clinical Research Site
Quilmes, Buenos Aires, Argentina · Recruiting
WB Contracted Clinical Research Site
Buenos Aires, Buenos Aires F.D., Argentina · Recruiting
WB Contracted Clinical Research Site
Buenos Aires, Buenos Aires F.D., Argentina · Recruiting
WB Contracted Clinical Research Site
Córdoba, Córdoba Province, Argentina · Recruiting
WB Contracted Clinical Research Site
Buenos Aires, Mendoza Province, Argentina · Recruiting
WB Contracted Clinical Research Site
Mendoza, Mendoza Province, Argentina · Recruiting
WB Contracted Clinical Research Site
Mendoza, Mendoza Province, Argentina · Recruiting
WB Contracted Clinical Research Site
Rosario, Santa Fe Province, Argentina · Recruiting
WB Contracted Clinical Research Site
Rosario, Santa Fe Province, Argentina · Recruiting
WB Contracted Clinical Research Site
Rosario, Santa Fe Province, Argentina · Recruiting
WB Contracted Clinical Research Site
Santa Fe, Santa Fe Province, Argentina · Recruiting
WB Contracted Clinical Research Site
San Miguel de Tucumán, Tucumán Province, Argentina · Recruiting
WB Contracted Clinical Research Site
San Miguel de Tucumán, Tucumán Province, Argentina · Recruiting
WB Contracted Clinical Research Site
San Miguel de Tucumán, Tucumán Province, Argentina · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.